Our previous research on PI3Kγ inhibition highlighted the ability of HNSCC tumors to promote PD-L1 expression in the tumor microenvironment as a potential mechanism to evade the favorable immune response elicited by PI3Kγ inhibition.17 This evidence concerns the gene CD274 and head and neck squamous cell carcinoma.